Literature DB >> 2878469

Cholinergic dysfunction in Alzheimer disease: cause or effect?

D A Plotkin, L F Jarvik.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1986        PMID： 2878469     DOI： 10.1016/S0079-6123(08)60644-5

Source DB:  PubMed          Journal:  Prog Brain Res        ISSN： 0079-6123            Impact factor:   2.453


× No keyword cloud information.
  4 in total

1.  MKC-231, a choline uptake enhancer, ameliorates working memory deficits and decreased hippocampal acetylcholine induced by ethylcholine aziridinium ion in mice.

Authors:  S Murai; H Saito; E Abe; Y Masuda; J Odashima; T Itoh
Journal:  J Neural Transm Gen Sect       Date:  1994

2.  Reversal effect of DM-9384 on scopolamine-induced acetylcholine depletion in certain regions of the mouse brain.

Authors:  E Abe
Journal:  Psychopharmacology (Berl)       Date:  1991       Impact factor: 4.530

3.  Effects of nefiracetam on deficits in active avoidance response and hippocampal cholinergic and monoaminergic dysfunctions induced by AF64A in mice.

Authors:  E Abe; S Murai; H Saito; Y Masuda; Y Takasu; T Shiotani; H Tachizawa; T Itoh
Journal:  J Neural Transm Gen Sect       Date:  1994

Review 4.  GSK-3β, a pivotal kinase in Alzheimer disease.

Authors:  María Llorens-Martín; Jerónimo Jurado; Félix Hernández; Jesús Avila
Journal:  Front Mol Neurosci       Date:  2014-05-21       Impact factor: 5.639
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.